{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:20:49Z","timestamp":1743567649798,"version":"3.40.3"},"reference-count":77,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206234","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T17:50:00Z","timestamp":1743529800000},"source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma"],"prefix":"10.18632","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Key Laboratory of Hematology of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Jia","sequence":"additional","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guirong","family":"Cui","sequence":"additional","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Qin","sequence":"additional","affiliation":[{"name":"MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Tianjin 300020, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Kong","sequence":"additional","affiliation":[{"name":"Hematology Department, Handan First Hospital, Handan 056001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma.","volume":"39","author":"Yong","year":"2021","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma.","volume":"3","author":"Anderson","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.32604\/biocell.2023.046640","article-title":"Immune checkpoint receptors and their ligands on CD8 T cells and myeloma cells in extramedullary multiple myeloma.","volume":"4","author":"Zang","year":"2024","journal-title":"Biocell"},{"key":"4","doi-asserted-by":"publisher","first-page":"e81184","DOI":"10.7554\/eLife.81184","article-title":"Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.","volume":"1","author":"Iorio","year":"2023","journal-title":"Elife"},{"key":"5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","article-title":"Multiple myeloma: signaling pathways and targeted therapy.","volume":"5","author":"Tong","year":"2024","journal-title":"Mol Biomed"},{"key":"6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1182\/blood.2023019637","article-title":"IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact.","volume":"14","author":"Pawlyn","year":"2023","journal-title":"Blood"},{"key":"7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40262-023-01240-8","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab.","volume":"6","author":"Phelps","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.clml.2015.07.641","article-title":"Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.","volume":"1","author":"Champlin","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3390\/cancers11122015","article-title":"Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies.","volume":"1","author":"Gay","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10","doi-asserted-by":"publisher","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","article-title":"Programmed Cell Death Tunes Tumor Immunity.","volume":"1","author":"Hu","year":"2022","journal-title":"Front Immunol"},{"key":"11","doi-asserted-by":"publisher","first-page":"C1444","DOI":"10.1152\/ajpcell.00246.2022","article-title":"Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection.","volume":"32","author":"Subbian","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"12","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.","volume":"10","author":"Xie","year":"2022","journal-title":"Int J Surg"},{"key":"13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications.","volume":"2","author":"Strasser","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.32604\/chd.2023.026262","article-title":"Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates.","volume":"1","author":"Kumar","year":"2023","journal-title":"Congenit Heart Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ijms24010644","article-title":"Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.","volume":"2","author":"Pandey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.gendis.2023.03.010","article-title":"Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma.","volume":"1","author":"Ding","year":"2023","journal-title":"Genes Dis"},{"key":"17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12672-024-00924-2","article-title":"A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.","volume":"1","author":"Feng","year":"2024","journal-title":"Discov Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.7150\/jca.92201","article-title":"Constructing a Prognostic Model of Uterine Corpus Endometrial Carcinoma and Predicting Drug-Sensitivity Responses Using Programmed Cell Death-Related Pathways.","volume":"1","author":"Zhao","year":"2024","journal-title":"J Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s10495-024-01960-7","article-title":"Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning.","volume":"2","author":"Yu","year":"2024","journal-title":"Apoptosis"},{"key":"20","doi-asserted-by":"publisher","first-page":"17874","DOI":"10.1038\/s41598-024-68755-3","article-title":"Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.","volume":"1","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.","volume":"2","author":"Hayes","year":"2010","journal-title":"Bioinformatics"},{"key":"22","doi-asserted-by":"publisher","first-page":"bbaa176","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.","volume":"2","author":"Guo","year":"2021","journal-title":"Brief Bioinform"},{"key":"23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance.","volume":"1","author":"Liu","year":"2020","journal-title":"Genome Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"2","author":"Brown","year":"2018","journal-title":"Nat Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","article-title":"Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.","volume":"2","author":"Cao","year":"2023","journal-title":"J Transl Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"27","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.ymthe.2021.03.003","article-title":"Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers.","volume":"2","author":"Di","year":"2021","journal-title":"Mol Ther"},{"key":"28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"4","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"29","unstructured":"Therneau, Lumley. Package \u2018 survival \u2018. 2015."},{"key":"30","first-page":"1","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent.","volume":"3","author":"Tibshirani","year":"2010","journal-title":"J Stat Softw"},{"key":"31","unstructured":"Blanche. timeROC: Time-Dependent ROC Curve and AUC for Censored Survival Data. 2015."},{"key":"32","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predictingor cancer patient drug response and biomarkers from cell line screening data.","volume":"2","author":"Huang","year":"2021","journal-title":"Brief Bioinform"},{"key":"33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","article-title":"Drug resistance in multiple myeloma.","volume":"7","author":"Robak","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","article-title":"Cell death, therapeutics, and the immune response in cancer.","volume":"9","author":"Ruffell","year":"2023","journal-title":"Trends Cancer"},{"key":"35","first-page":"231","article-title":"Application and Development of Targeted Fishing Technology in Natural Product Screening - A Simple Minireview.","volume":"2","author":"Qin","year":"2024","journal-title":"Current Pharmaceutical Analysis"},{"key":"36","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.ebiom.2023.104920","article-title":"Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma.","volume":"9","author":"Ma","year":"2024","journal-title":"EBioMedicine"},{"key":"37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41698-024-00538-5","article-title":"Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy.","volume":"8","author":"Huang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"845074","DOI":"10.3389\/fonc.2022.845074","article-title":"Integrative Analysis of a Pyroptosis-Related Signature of Clinical and Biological Value in Multiple Myeloma.","volume":"1","author":"Lu","year":"2022","journal-title":"Front Oncol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1203125","DOI":"10.3389\/fphar.2023.1203125","article-title":"Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma.","volume":"1","author":"Dong","year":"2023","journal-title":"Front Pharmacol"},{"key":"40","doi-asserted-by":"publisher","first-page":"3922739","DOI":"10.1155\/2022\/3922739","article-title":"Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma.","volume":"202","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"1100170","DOI":"10.3389\/fgene.2023.1100170","article-title":"Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma.","volume":"1","author":"Wu","year":"2023","journal-title":"Front Genet"},{"key":"42","first-page":"327","article-title":"Robust U-HPLC Method Development of Desonide and its Application toRelease Testing (IVRT) of Topical Cream Products.","volume":"2","author":"Yusuff","year":"2024","journal-title":"Current Pharmaceutical Analysis"},{"key":"43","doi-asserted-by":"publisher","first-page":"175087","DOI":"10.1016\/j.ejphar.2022.175087","article-title":"Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?","volume":"92","author":"Khori","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy.","volume":"2","author":"Garlanda","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"45","doi-asserted-by":"publisher","first-page":"117045","DOI":"10.1016\/j.biopha.2024.117045","article-title":"CAFs and T cells interplay: The emergence of a new arena in cancer combat.","volume":"17","author":"Song","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/vaccines4040036","article-title":"The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression.","volume":"4","author":"Utikal","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"47","doi-asserted-by":"publisher","first-page":"921182","DOI":"10.3389\/fimmu.2022.921182","article-title":"Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer.","volume":"1","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fonc.2014.00348","article-title":"Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.","volume":"4","author":"Tassone","year":"2014","journal-title":"Front Oncol"},{"key":"49","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/bcj.2013.34","article-title":"Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg\/Th17 balance.","volume":"3","author":"Joshua","year":"2013","journal-title":"Blood Cancer J"},{"key":"50","doi-asserted-by":"publisher","first-page":"e000442","DOI":"10.1136\/esmoopen-2018-000442","article-title":"Implementing TMB measurement in clinical practice: considerations on assay requirements.","volume":"4","author":"Penault-Llorca","year":"2019","journal-title":"ESMO Open"},{"key":"51","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","article-title":"The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.","volume":"1","author":"Fridman","year":"2020","journal-title":"Front Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy.","volume":"13","author":"Sansom","year":"2018","journal-title":"Blood"},{"key":"53","doi-asserted-by":"publisher","first-page":"e16364","DOI":"10.7717\/peerj.16364","article-title":"Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.","volume":"1","author":"Liu","year":"2023","journal-title":"PeerJ"},{"key":"54","doi-asserted-by":"publisher","first-page":"e2300050","DOI":"10.1002\/adbi.202300050","article-title":"TIGIT may Serve as a Potential Target for the Immunotherapy of Renal Cell Carcinoma.","volume":"8","author":"Wang","year":"2024","journal-title":"Adv Biol (Weinh)"},{"key":"55","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.3390\/ijms22179298","article-title":"Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.","volume":"2","author":"Kosmaczewska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"56","doi-asserted-by":"publisher","first-page":"120727","DOI":"10.1016\/j.lfs.2022.120727","article-title":"HMGB3 inhibition by miR-142-3p\/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells.","volume":"30","author":"Karunagaran","year":"2022","journal-title":"Life Sci"},{"key":"57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10528-024-10671-2","article-title":"The Combinatorial Effect of Ad-IL-24 and Ad-HSV-tk\/GCV on Tumor Size, Autophagy, and UPR Mechanisms in Multiple Myeloma Mouse Model.","volume":"6","author":"Baesi","year":"2025","journal-title":"Biochem Genet"},{"key":"58","doi-asserted-by":"publisher","first-page":"20332","DOI":"10.1002\/cam4.6619","article-title":"Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma.","volume":"1","author":"Malavasi","year":"2023","journal-title":"Cancer Med"},{"key":"59","first-page":"2895","article-title":"CD38 triggers inflammasome-mediated pyroptotic cell death in head and neck squamous cell carcinoma.","volume":"1","author":"Wong","year":"2020","journal-title":"Am J Cancer Res"},{"key":"60","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood.2023020528","article-title":"Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8\u03b1\u03b2+ T cells targeting multiple myeloma.","volume":"14","author":"Kaneko","year":"2024","journal-title":"Blood"},{"key":"61","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","article-title":"Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.","volume":"18","author":"Yu","year":"2024","journal-title":"Cell"},{"key":"62","doi-asserted-by":"publisher","first-page":"127517","DOI":"10.1016\/j.jtemb.2024.127517","article-title":"The novel prognostic analysis of AML based on ferroptosis and cuproptosis related genes.","volume":"8","author":"Kong","year":"2024","journal-title":"J Trace Elem Med Biol"},{"key":"63","first-page":"1387","article-title":"Effect of RhoC silencing on multiple myeloma xenografts and angiogenesis in nude mice.","volume":"3","author":"Chen","year":"2019","journal-title":"J Biol Regul Homeost Agents"},{"key":"64","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1159\/000487730","article-title":"Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma.","volume":"4","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"65","doi-asserted-by":"publisher","first-page":"110859","DOI":"10.1016\/j.intimp.2023.110859","article-title":"Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma.","volume":"12","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"66","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.18632\/aging.205591","article-title":"4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.","volume":"1","author":"Ying","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"67","doi-asserted-by":"publisher","first-page":"127517","DOI":"10.3389\/fgene.2022.996291","article-title":"A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma.","volume":"8","author":"Xu","year":"2022","journal-title":"Front Genet"},{"key":"68","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1089\/cmb.2019.0397","article-title":"Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.","volume":"2","author":"Wang","year":"2020","journal-title":"J Comput Biol"},{"key":"69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.biopha.2018.04.190","article-title":"Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer.","volume":"10","author":"Sun","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.omto.2020.10.004","article-title":"Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma.","volume":"1","author":"Zhang","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"71","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41388-021-02112-w","article-title":"Tight junction protein 1 promotes vasculature remodeling via regulating USP2\/TWIST1 in bladder cancer.","volume":"4","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.20517\/2394-4722.2021.35","article-title":"The multifunctional role of Notch signaling in multiple myeloma.","volume":"7","author":"Delgado-Calle","year":"2021","journal-title":"J Cancer Metastasis Treat"},{"key":"73","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.","volume":"7","author":"Bellido","year":"2016","journal-title":"Cancer Res"},{"key":"74","doi-asserted-by":"publisher","first-page":"20004","DOI":"10.1073\/pnas.2005052117","article-title":"Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma.","volume":"11","author":"Orlowski","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"75","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/ijc.34044","article-title":"The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.","volume":"15","author":"Ormanns","year":"2022","journal-title":"Int J Cancer"},{"key":"76","doi-asserted-by":"publisher","first-page":"954524","DOI":"10.3389\/fmolb.2022.954524","article-title":"Ferroptosis-related gene signature predicts the clinical outcome in pediatric acute myeloid leukemia patients and refines the 2017 ELN classification system.","volume":"9","author":"You","year":"2022","journal-title":"Front Mol Biosci"},{"key":"77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12935-019-0896-9","article-title":"Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells.","volume":"1","author":"Tao","year":"2019","journal-title":"Cancer Cell Int"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T17:51:17Z","timestamp":1743529877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":77,"alternative-id":["206234"],"URL":"https:\/\/doi.org\/10.18632\/aging.206234","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}